Large vessel vasculitis in elderly patients: early diagnosis and steroid-response evaluation with FDG-PET/CT and contrast-enhanced CT

被引:30
作者
Muto, Go [1 ]
Yamashita, Hiroyuki [1 ]
Takahashi, Yuko [1 ]
Miyata, Yoko [2 ]
Morooka, Miyako [2 ]
Minamimoto, Ryogo [2 ]
Kubota, Kazuo [2 ]
Kaneko, Hiroshi [1 ]
Kano, Toshikazu [1 ]
Mimori, Akio [1 ]
机构
[1] Natl Ctr Global Hlth & Med, Div Rheumat Dis, Shinjuku Ku, Tokyo 1628655, Japan
[2] Natl Ctr Global Hlth & Med, Dept Radiol, Shinjuku Ku, Tokyo 1628655, Japan
关键词
Large vessel vasculitis; Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography; Contrast-enhanced CT; Inflammation of unknown origin; GIANT-CELL ARTERITIS; POSITRON-EMISSION-TOMOGRAPHY; RHEUMATOLOGY; 1990; CRITERIA; TAKAYASU ARTERITIS; POLYMYALGIA-RHEUMATICA; AORTITIS; CLASSIFICATION; REGISTRATION; INFLAMMATION; MANAGEMENT;
D O I
10.1007/s00296-014-2985-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Large vessel vasculitis (LVV) is an often-reported cause of inflammation of unknown origin (IUO) in elderly people. The objective of this study was to describe the usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and contrast-enhanced CT in early diagnosis and treatment follow-up of patients with LVV presenting as elderly onset IUO. We retrospectively compared contrast-enhanced CT findings and FDG-PET/CT findings of the patients diagnosed with LVV and 11 controls; all subjects were 50 years of age or older. We evaluated maximum standardised uptake value (SUVmax) and PET score of the aortic wall for quantitative comparison of FDG-PET/CT findings. We measured the aortic wall thickness (W) and its ratio against the radius (W/R) for quantitative comparison of aortic wall thickening by contrast-enhanced CT. After steroid treatment, we compared these values with those pre-treatment. Of 124 patients who were hospitalised due to advanced age and IUO, 88 underwent FDG-PET/CT and contrast-enhanced CT. Abnormal findings were observed on images from 78 patients. The findings were indicative of LVV in 13 patients (10.5 %), of whom more than half had only non-specific symptoms. Patients with LVV had significantly higher aortic wall SUVmax (3.85 vs. 1.95), PET scores by FDG-PET/CT, and aortic wall thicknesses by contrast-enhanced CT (3.8 vs. 2.6 mm) than controls. Significant improvement in aortic wall thickening was evidenced by reduced PET scores and by contrast-enhanced CT findings in patients who were followed up after treatment. LVV is an important cause of IUO with non-specific symptoms in elderly patients. Imaging examination comprising contrast-enhanced CT and FDG-PET/CT is useful for early diagnosis and early treatment evaluation of LVV, allowing for amelioration of reversible aortic wall thickening.
引用
收藏
页码:1545 / 1554
页数:10
相关论文
共 41 条
[1]  
AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129
[2]   Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis [J].
Besson, Florent L. ;
Parienti, Jean-Jacques ;
Bienvenu, Boris ;
Prior, John O. ;
Costo, Sylvie ;
Bouvard, Gerard ;
Agostini, Denis .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (09) :1764-1772
[3]   Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis:: A prospective study of 35 patients [J].
Blockmans, D ;
De Ceuninck, L ;
Vanderschueren, S ;
Knockaert, D ;
Mortelmans, L ;
Bobbaers, H .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (01) :131-137
[4]   Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: Evidence for inflammation of the aortic arch [J].
Blockmans, D ;
Stroobants, S ;
Maes, A ;
Mortelmans, L .
AMERICAN JOURNAL OF MEDICINE, 2000, 108 (03) :246-249
[5]  
Brack A, 1999, ARTHRITIS RHEUM, V42, P311, DOI 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO
[6]  
2-F
[7]   The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries [J].
Brodmann, M ;
Lipp, RW ;
Passath, A ;
Seinost, G ;
Pabst, E ;
Pilger, E .
RHEUMATOLOGY, 2004, 43 (02) :241-242
[8]  
CORREIA JA, 1990, J NUCL MED, V31, P1227
[9]  
de Leeuw K, 2004, CLIN EXP RHEUMATOL, V22, pS21
[10]  
Durack D T, 1991, Curr Clin Top Infect Dis, V11, P35